Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Kaufman, Howard
Item TypeName
Concept Vaccinia virus
Academic Article Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity.
Academic Article Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses.
Academic Article Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.
Academic Article Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma.
Academic Article 4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines.
Academic Article Poxviruses as vectors for cancer immunotherapy.
Academic Article Host lymphodepletion enhances the therapeutic activity of an oncolytic vaccinia virus expressing 4-1BB ligand.
Academic Article Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma.
Academic Article Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer.
Academic Article Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
Academic Article Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.
Academic Article Specific immunotherapy using a recombinant vaccinia virus expressing human carcinoembryonic antigen.
Academic Article Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model.
Academic Article The next generation of vaccines for the treatment of cancer.
Academic Article Immune properties of recombinant vaccinia virus encoding CD154 (CD40L) are determined by expression of virally encoded CD40L and the presence of CD40L protein in viral particles.
Academic Article Local delivery of vaccinia virus expressing multiple costimulatory molecules for the treatment of established tumors.
Academic Article Administration of vaccinia virus to mice may cause contact or bedding sentinel mice to test positive for orthopoxvirus antibodies: case report and follow-up investigation.
Academic Article Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer.
Academic Article TG-4010 Transgene.
Academic Article A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA).
Academic Article Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer.
Grant ENHANCING TUMOR VACCINES WITH CO-STIMULATORY MOLECULES
Search Criteria
  • Vaccinia virus
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.